WILLIAMS AND JENSEN, PLLC for NOVARTIS INC
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report | Oct 18, 2013 | $60,000 | Replaced |
| 3rd Quarter - Amendment (this page) | Mar 4, 2014 | $80,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Drug safety and drug counterfeiting (track and trace); Drug importation; Authorized generics; Drug company patent settlements; Prescription drug advertising; Federal preemption for prescription drugs; implementation of the Patient Protection and Affordable Care Act;and drug shortages.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL BEER New | LA, Rep. Dave Hobson |
| JENNY DIJAMES New | LA and LD, Rep. Bud Cramer |
| JACK STEVEN HART New | — |
| SUSAN HIRSCHMANN | — |
| MATTHEW B HOEKSTRA | — |
| KARINA LYNCH | — |
| MELINDA M MAXFIELD | — |
| ERIN BOOK MULLEN | — |
| GEORGE OLSEN | — |
Medicare/Medicaid MMM
Medicare prescription drug benefit; Rebates for Medicare Part D; Independent Payment Advisory Board (IPAB). House and Senate Budget resolutions. Tax Application of the ACA section 9008 to orphan drugs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNY DIJAMES | — |
| SUSAN HIRSCHMANN | — |
| KARINA LYNCH | — |
| GEORGE OLSEN | — |
Budget/Appropriations BUD
Funding for pandemic influenza countermeasures.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW B HOEKSTRA | — |
| GEORGE OLSEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.